(State or other jurisdiction of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification Number) |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading symbol
|
Name of each exchange on which registered
|
||
$0.001 par value per share
|
|
|
ASENSUS SURGICAL, INC. | |
Date: September 19, 2023 | /s/ Shameze Rampertab |
Shameze Rampertab | |
Executive Vice President and Chief Financial Officer |
Document And Entity Information |
Sep. 19, 2023 |
---|---|
Document Information [Line Items] | |
Entity, Registrant Name | Asensus Surgical, Inc. |
Document, Type | 8-K |
Document, Period End Date | Sep. 19, 2023 |
Entity, Incorporation, State or Country Code | DE |
Entity, File Number | 0-19437 |
Entity, Tax Identification Number | 11-2962080 |
Entity, Address, Address Line One | 1 TW Alexander Drive, Suite 160 |
Entity, Address, City or Town | Durham |
Entity, Address, State or Province | NC |
Entity, Address, Postal Zip Code | 27703 |
City Area Code | 919 |
Local Phone Number | 765-8400 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | ASXC |
Security Exchange Name | NYSE |
Entity, Emerging Growth Company | false |
Amendment Flag | false |
Entity, Central Index Key | 0000876378 |
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end
?F6-*X\F4OV:3F\\6O;)_CZ]=:O;9_@Z][U
M7]L^N4WH0NU#[NKTEX_9W;,[W#+/-9;6.NEUYHME'>LG$"S-'0TL,*'5EUBC
MDZO3B\_G2U2D_R3E==4\;5N_=-K-CU;SI-?NU CU;NA,+@LA16TLY-)60EZ(
M;